help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takiyama, Y.
Right arrow Articles by Tateno, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takiyama, Y.
Right arrow Articles by Tateno, M.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 11 5851-5861
Copyright © 2004 by The Endocrine Society

Decreased Expression of Retinoid X Receptor Isoforms in Human Thyroid Carcinomas

Yumi Takiyama, Naoyuki Miyokawa, Akira Sugawara, Shizuo Kato, Koichi Ito, Keisuke Sato, Kensuke Oikawa, Hiroya Kobayashi, Shoji Kimura and Masatoshi Tateno

The Second Department of Pathology (Y.T., K.S., K.O., H.K., M.T.), Surgical Pathology (N.M., S.Ka.), and School of Nursing (S.Ki.), School of Medicine, Asahikawa Medical College, Asahikawa 078-8510, Japan; Department of Comprehensive Medicine (A.S.), Tohoku University, Sendai 980-8578, Japan; and Ito Hospital (K.I.), Tokyo 150-8308, Japan

Address all correspondence and requests for reprints to: Yumi Takiyama, M.D., Ph.D., The Second Department of Internal Medicine, Asahikawa Medical College, Midorigaoka higashi 2-1-1-1, Asahikawa 078-8510, Japan. E-mail: taka0716{at}asahikawa-med.ac.jp.

Retinoid X receptors (RXRs) are ligand-inducible transcription factors that belong to the superfamily of nuclear hormone receptors. Because RXRs heterodimerize with thyroid hormone receptor, retinoic acid receptor, vitamin D3 receptor, and peroxisome proliferator-activated receptor, they play central roles in regulating a number of signaling pathways. To understand the roles of RXRs in human thyroid carcinogenesis, we have investigated the immunohistochemical expression of RXRs in normal and neoplastic thyroid tissues. Whereas nontumorous human thyroid cells exhibited distinct nuclear staining for the RXRs, thyroid carcinomas showed decreased nuclear expression of all three RXR isoforms. In particular, some thyroid carcinoma cells showed intense RXR-{alpha} cytoplasmic staining accompanied by decreased immunoreactivity in their nuclei. This subcellular localization of RXR-{alpha} was confirmed by Western blot analysis, which showed both lower nuclear expression levels of RXR-{alpha} and a cytosolic presence of RXR-related protein in neoplastic regions. We present here, for the first time, the histological distribution of each RXR protein ({alpha}, ß, and {gamma}) in human thyroid follicular cells. In addition, we found that the nuclear expression of RXRs was lower in thyroid carcinomas than in normal tissue. The differential expressions of these RXRs in thyroid carcinomas might be implicated in the pathogenesis of thyroid cancers.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J. P. Klopper, A. Berenz, W. R. Hays, V. Sharma, U. Pugazhenthi, J. Janssen, M. Singh, R. P. Bissonnette, and B. R. Haugen
In vivo and Microarray Analysis of Rexinoid-Responsive Anaplastic Thyroid Carcinoma
Clin. Cancer Res., January 15, 2008; 14(2): 589 - 596.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Xiao, X. Hao, B. Simi, J. Ju, H. Jiang, B. S. Reddy, and C. S. Yang
Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats
Carcinogenesis, January 1, 2008; 29(1): 113 - 119.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Chakravarti, R. Lotan, A. H. Diwan, C. L. Warneke, M. M. Johnson, and V. G. Prieto
Decreased Expression of Retinoid Receptors in Melanoma: Entailment in Tumorigenesis and Prognosis
Clin. Cancer Res., August 15, 2007; 13(16): 4817 - 4824.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society